European watchdog starts safety review of Merck cholesterol drug

Written By Unknown on Friday, 21 December 2012 | 06:28


LONDON |
Fri Dec 21, 2012 7:16am EST

LONDON (Reuters) – The European Medicines Agency pronounced it has launched a examination of Merck Co Inc’s cholesterol drug Tredaptive after a medicine unsuccessful a U.S. hearing assessing a efficacy and safety.

Although a blurb fallout from any preference to lift a drug from a marketplace in Europe would be limited, it would be a blow to Merck’s reputation.

Bernstein researcher Tim Anderson estimates that Tredaptive sales in Europe and other non-U.S. markets are using during usually around $50 million a

Read full article: http://online.wsj.com/article/SB10001424127887324894104578109000926531558.html


Source:
http://www.ezonearticle.com/2012/12/21/european-watchdog-starts-safety-review-of-merck-cholesterol-drug/

0 comments:

Post a Comment